Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer
Okay, the user is posing a high-stakes scenario as the CEO of a pharmaceutical company facing a serious drug safety issue. This is clearly a crisis management test that requires balancing multiple competing priorities. Hmm, the core tension here is between immediate patient safety versus corporate survival.Read the full answer